Akero Therapeutics, Inc.

UBS Group AG AKRO

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/13/2025

Shares

335,678

Value ($000)

15,938

Weight

0.0%

2019 Q4 - 2025 Q3 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/13/2025	15,938	0.0%	335,678	9/30/2025
2025 Q2	8/14/2025	108,261	0.0%	2,028,887	6/30/2025
2025 Q1	5/13/2025	87,291	0.0%	2,156,406	3/31/2025
2024 Q4	2/14/2025	10,345	0.0%	371,844	12/31/2024
2024 Q3	11/14/2024	2,720	0.0%	94,801	9/30/2024
2024 Q2	8/14/2024	1,668	0.0%	71,111	6/30/2024
2024 Q1	5/13/2024	5,254	0.0%	208,001	3/31/2024
2023 Q4	2/9/2024	6,220	0.0%	266,386	12/31/2023
2023 Q3	11/9/2023	2,954	0.0%	58,403	9/30/2023
2023 Q2	8/11/2023	1,234	0.0%	26,435	6/30/2023
2023 Q1	5/12/2023	3,575	0.0%	93,432	3/31/2023
2022 Q4	2/8/2023	7,616	0.0%	138,980	12/31/2022
2022 Q3	11/10/2022	127	0.0%	3,718	9/30/2022
2022 Q2	8/10/2022	33	0.0%	3,500	6/30/2022
2022 Q1	5/16/2022	945	0.0%	66,565	3/31/2022
2021 Q4	2/14/2022	1,203	0.0%	56,840	12/31/2021
2021 Q3	11/15/2021	967	0.0%	43,252	9/30/2021
2021 Q2	8/13/2021	255	0.0%	10,301	6/30/2021
2021 Q1	5/12/2021	830	0.0%	28,609	3/31/2021
2020 Q4	2/11/2021	159	0.0%	6,154	12/31/2020
2020 Q3	11/12/2020	52	0.0%	1,691	9/30/2020
2020 Q2	7/31/2020	36	0.0%	1,452	6/30/2020
2020 Q1	5/1/2020	21	0.0%	1,011	3/31/2020
2019 Q4	2/14/2020	72	0.0%	3,261	12/31/2019